Price T Rowe Associates Inc Generation Bio Co. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 9,351,590 shares of GBIO stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,351,590
Previous 9,513,626
1.7%
Holding current value
$12.8 Million
Previous $26.8 Million
13.9%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding GBIO
# of Institutions
76Shares Held
49.6MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC8.28MShares$11.3 Million2.52% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.92MShares$5.37 Million0.16% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$4.51 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.98MShares$4.09 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.98MShares$4.09 Million0.37% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $80.8M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...